Literature DB >> 11720447

Protoporphyrin IX distribution following local application of 5-aminolevulinic acid and its esterified derivatives in the tissue layers of the normal rat colon.

E Endlicher1, P Rümmele, F Hausmann, R Krieg, R Knüchel, H C Rath, J Schölmerich, H Messmann.   

Abstract

Photodynamic diagnosis and especially therapy after sensitization with 5-aminolevulinic acid (ALA) is hampered by limitations of uptake and distribution of ALA due to its hydrophilic nature. Chemical modification of ALA into its more lipophilic esters seems to be promising to overcome these problems. The aim of the present study was to investigate the comparative kinetics of protoporphyrin IX (PPIX) fluorescence in rat colonic tissue after topical application of ALA and its esterified derivatives, ALA-hexylester (h-ALA), ALA-methylester (m-ALA) and ALA-benzylester (b-ALA). Fluorescence intensity induced by PPIX in normal colonic tissue was quantified using fluorescence microscopy at 1, 2, 4, 6 and 8 h after sensitization. Mucosa exhibited higher fluorescence levels compared to the underlying submucosa or smooth muscle. Peak fluorescence intensities were seen 4 h after local sensitization with 86.0 mol ml(-1) ALA (513 +/- 0.57 counts per pixel), 6.6 mol ml(-1) m-ALA (508 +/- 35.50) and 4.8 mol ml(-1) h-ALA (532 +/- 128.80), and 6 h after sensitization with 4.6 mol ml(-1) b-ALA (468 +/- 190.27). A 13-18 times lower concentration of ALA esters was required for fluorescence intensities reached with ALA alone. A similar degree of the fluorescence ratio between mucosa and muscularis (5-6:1) was detected for ALA and its derivatives. The time point of the maximum value of this ratio was consistent with peak fluorescence levels for ALA and each ALA-ester. The clinical feasibility and the advantages of topical ALA ester-based fluorescence for detection of malignant and premalignant lesions need further investigations.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11720447      PMCID: PMC2363929          DOI: 10.1054/bjoc.2001.2124

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  17 in total

1.  Use of 5-aminolevulinic acid esters to improve photodynamic therapy on cells in culture.

Authors:  J M Gaullier; K Berg; Q Peng; H Anholt; P K Selbo; L W Ma; J Moan
Journal:  Cancer Res       Date:  1997-04-15       Impact factor: 12.701

Review 2.  5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges.

Authors:  Q Peng; T Warloe; K Berg; J Moan; M Kongshaug; K E Giercksky; J M Nesland
Journal:  Cancer       Date:  1997-06-15       Impact factor: 6.860

3.  Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence.

Authors:  M Kriegmair; R Baumgartner; R Knüchel; H Stepp; F Hofstädter; A Hofstetter
Journal:  J Urol       Date:  1996-01       Impact factor: 7.450

4.  Derivatives of 5-aminolevulinic acid for photodynamic therapy: enzymatic conversion into protoporphyrin.

Authors:  J Kloek; W Akkermans; G M Beijersbergen van Henegouwen
Journal:  Photochem Photobiol       Date:  1998-01       Impact factor: 3.421

5.  5-aminolevulinic acid, but not 5-aminolevulinic acid esters, is transported into adenocarcinoma cells by system BETA transporters.

Authors:  E Rud; O Gederaas; A Høgset; K Berg
Journal:  Photochem Photobiol       Date:  2000-05       Impact factor: 3.421

6.  Cell-type specific protoporphyrin IX metabolism in human bladder cancer in vitro.

Authors:  R C Krieg; S Fickweiler; O S Wolfbeis; R Knuechel
Journal:  Photochem Photobiol       Date:  2000-08       Impact factor: 3.421

7.  Endoscopic fluorescence detection of low and high grade dysplasia in Barrett's oesophagus using systemic or local 5-aminolaevulinic acid sensitisation.

Authors:  E Endlicher; R Knuechel; T Hauser; R M Szeimies; J Schölmerich; H Messmann
Journal:  Gut       Date:  2001-03       Impact factor: 23.059

8.  Photosensitisation and photodynamic therapy of oesophageal, duodenal, and colorectal tumours using 5 aminolaevulinic acid induced protoporphyrin IX--a pilot study.

Authors:  J Regula; A J MacRobert; A Gorchein; G A Buonaccorsi; S M Thorpe; G M Spencer; A R Hatfield; S G Bown
Journal:  Gut       Date:  1995-01       Impact factor: 23.059

9.  Fluorescence distribution and photodynamic effect of ALA-induced PP IX in the DMH rat colonic tumour model.

Authors:  J Bedwell; A J MacRobert; D Phillips; S G Bown
Journal:  Br J Cancer       Date:  1992-06       Impact factor: 7.640

10.  Oral versus intravenous administration of 5-aminolaevulinic acid for photodynamic therapy.

Authors:  C S Loh; A J MacRobert; J Bedwell; J Regula; N Krasner; S G Bown
Journal:  Br J Cancer       Date:  1993-07       Impact factor: 7.640

View more
  2 in total

1.  Fluorescence contrast-enhanced proliferative lesion imaging by enema administration of indocyanine green in a rat model of colon carcinogenesis.

Authors:  Nobuhiko Onda; Reiko Mizutani-Morita; Susumu Yamashita; Rei Nagahara; Shinya Matsumoto; Toshinori Yoshida; Makoto Shibutani
Journal:  Oncotarget       Date:  2017-10-09

2.  ALA and ALA hexyl ester induction of porphyrins after their systemic administration to tumour bearing mice.

Authors:  C Perotti; A Casas; H Fukuda; P Sacca; A Batlle
Journal:  Br J Cancer       Date:  2002-09-23       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.